Possibility of Using the Embryo Fetoplacental Complex Products to Correct Apoptotic Processes under Autoimmune Diseases
Keywords:apoptosis, rheumatoid arthritis, products of embryo fetoplacental complex
The authors have studied the activity of immune competent cells in an experimental model of rheumatoid arthritis in mice. There was demonstrated the possibility to apply the products of embryo fetoplacental complex (PEFPC) to modulate the apoptotic processes under autoimmune diseases (AIDs).
How to Cite
Goltsev, A. N., Grischenko, V. I., Rassokha, I. V., & Ostankov, M. V. (2003). Possibility of Using the Embryo Fetoplacental Complex Products to Correct Apoptotic Processes under Autoimmune Diseases. Problems of Cryobiology and Cryomedicine, (4), 41–48. Retrieved from https://cryo.org.ua/journal/index.php/probl-cryobiol-cryomed/article/view/1077
Theoretical and Experimental Cryobiology
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).